CoChat

Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis

Open access
Kalavalapalli, Srilaxmi, Bril, Fernando, Koelmel, Jeremy P., Abdo, Kaitlyn, Guingab, Joy, Andrews, Paige, Li, Wen-Yi, Jose, Dhanya, Yost, Richard A., Frye, Reginald F., Garrett, Timothy J., Cusi, Kenneth, Sunny, Nishanth E. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
Cited by 66

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Pioglitazone is effective in improving insulin resistance and liver histology in patients with nonalcoholic steatohepatitis (NASH). Because dysfunctional mitochondrial metabolism is a central feature of NASH, we hypothesized that an important target of pioglitazone would be alleviating mitochondrial oxidative dysfunction. To this end, we studied hepatic mitochondrial metabolism in mice fed high-fructose high-transfat diet (TFD) supplemented with pioglitazone for 20 wk, using nuclear magnetic resonance-based 13 C isotopomer analysis. Pioglitazone improved whole body and adipose insulin sensitivity in TFD-fed mice. Furthermore, pioglitazone reduced intrahepatic triglyceride content and fed plasma ketones and hepatic TCA cycle flux, anaplerosis, and pyruvate cycling in mice with NASH. This was associated with a marked reduction in most intrahepatic diacylglycerol classes and, to a lesser extent, some ceramide species (C22:1, C23:0). Considering the cross-talk between mitochondrial function and branched-chain amino acid (BCAA) metabolism, pioglitazone’s impact on plasma BCAA profile was determined in a cohort of human subjects. Pioglitazone improved the plasma BCAA concentration profile in patients with NASH. This appeared to be related to an improvement in BCAA degradation in multiple tissues. These results provide evidence that pioglitazone-induced changes in NASH are related to improvements in hepatic mitochondrial oxidative dysfunction and changes in whole body BCAA metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00023.2018

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 66

Metadata

Authors
Kalavalapalli, S., Bril, F., Koelmel, J. P., Abdo, K., Guingab, J., Andrews, P., Li, W.-Y., Jose, D., Yost, R. A., Frye, R. F., Garrett, T. J., Cusi, K., & Sunny, N. E.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2018-08-01
Volume
315
Issue
2
Pages
E163-E173
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2797783284
Cited by
66
References
14
FWCI
6.14
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis. https://app.cochat.ai/papers/10.1152/ajpendo.00023.2018
The paper
Kalavalapalli, S., Bril, F., Koelmel, J. P., Abdo, K., Guingab, J., Andrews, P., Li, W.-Y., Jose, D., Yost, R. A., Frye, R. F., Garrett, T. J., Cusi, K., & Sunny, N. E. (2018). Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00023.2018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.